153 results
Search Results
2. A detailed overview of quercetin: implications for cell death and liver fibrosis mechanisms.
- Author
-
Fei Xiong, Yichen Zhang, Ting Li, Yiping Tang, Si-Yuan Song, Qiao Zhou, and Yi Wang
- Subjects
HEPATIC fibrosis ,CELL death ,CARBON tetrachloride ,QUERCETIN ,LIVER cells ,PHYSICAL organic chemistry ,FLAVONOIDS - Abstract
Background: Quercetin, a widespread polyphenolic flavonoid, is known for its extensive health benefits and is commonly found in the plant kingdom. The natural occurrence and extraction methods of quercetin are crucial due to its bioactive potential. Purpose: This review aims to comprehensively cover the natural sources of quercetin, its extraction methods, bioavailability, pharmacokinetics, and its role in various cell death pathways and liver fibrosis. Methods: A comprehensive literature search was performed across several electronic databases, including PubMed, Embase, CNKI, Wanfang database, and ClinicalTrials.gov, up to 10 February 2024. The search terms employedwere "quercetin", "natural sources of quercetin", "quercetin extraction methods", "bioavailability of quercetin", "pharmacokinetics of quercetin", "cell death pathways", "apoptosis", "autophagy", "pyroptosis", "necroptosis", "ferroptosis", "cuproptosis", "liver fibrosis", and "hepatic stellate cells". These keywords were interconnected using AND/OR as necessary. The search focused on studies that detailed the bioavailability and pharmacokinetics of quercetin, its role in different cell death pathways, and its effects on liver fibrosis. Results: This review details quercetin's involvement in various cell death pathways, including apoptosis, autophagy, pyroptosis, necroptosis, ferroptosis, and cuproptosis, with particular attention to its regulatory influence on apoptosis and autophagy. It dissects the mechanisms through which quercetin affects these pathways across different cell types and dosages. Moreover, the paper delves into quercetin's effectson liver fibrosis, its interactions with hepatic stellate cells, and its modulation of pertinent signaling cascades. Additionally, it articulates from a physical organic chemistry standpoint the uniqueness of quercetin's structure and its potential for specific actions in the liver. Conclusion: The paper provides a detailed analysis of quercetin, suggesting its significant role in modulating cell death mechanisms and mitigating liver fibrosis, underscoring its therapeutic potential. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Mechanism of Action of Dihydroquercetin in the Prevention and Therapy of Experimental Liver Injury.
- Author
-
Wei, Hewei, Zhao, Ting, Liu, Xinglong, Ding, Qiteng, Yang, Junran, Bi, Xiaoyu, Cheng, Zhiqiang, Ding, Chuanbo, and Liu, Wencong
- Subjects
ALCOHOLIC liver diseases ,BIOAVAILABILITY ,FATTY liver ,TREATMENT effectiveness ,LIVER injuries ,LIVER cells - Abstract
Liver disease is a global health problem that affects the well-being of tens of thousands of people. Dihydroquercetin (DHQ) is a flavonoid compound derived from various plants. Furthermore, DHQ has shown excellent activity in the prevention and treatment of liver injury, such as the inhibition of hepatocellular carcinoma cell proliferation after administration, the normalization of oxidative indices (like SOD, GSH) in this tissue, and the down-regulation of pro-inflammatory molecules (such as IL-6 and TNF-α). DHQ also exerts its therapeutic effects by affecting molecular pathways such as NF-κB and Nrf2. This paper discusses the latest research progress of DHQ in the treatment of various liver diseases (including viral liver injury, drug liver injury, alcoholic liver injury, non-alcoholic liver injury, fatty liver injury, and immune liver injury). It explores how to optimize the application of DHQ to improve its effectiveness in treating liver diseases, which is valuable for preparing potential therapeutic drugs for human liver diseases in conjunction with DHQ. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Potential value of liver macrophages and their plasticity in the treatment of ACLF.
- Author
-
CHEN Guirong, WANG Minggang, LIN Huaming, CHEN Xinxin, LUO Juan, YE Fengqin, and WANG Xiufeng
- Subjects
LIVER cells ,MACROPHAGES ,LIVER ,MULTIPLE organ failure ,CHARACTERISTIC functions - Abstract
Acute-on-chronic liver failure (ACLF) is a group of clinical syndromes related to severe acute liver function damage and multiple organ failure caused by various acute inducing factors on the basis of chronic liver disease. Due to its serious condition, rapid progression and high mortality, it has attracted more and more attention. Recent studies have shown that the pathogenesis of ACLF mainly includes direct injury and immune injury. As the main immune cells in the liver, the immunoregulatory role of liver macrophages in ACLF has been increasingly recognized. Liver macrophages have excellent phenotype conversion function and plasticity characteristics under the influence of epigenetic reprogramming or local microenvironment. This adaptive expression ability can use key mediators to promote the early conversion of anti-inflammatory phenotype to alleviate liver injury. A large number of studies have shown that liver macrophages have a certain potential in reversing the process of ACLF. Therefore, from the perspective of the plasticity characteristics of liver macrophages, this paper expounds the role of liver macrophages in ACLF and the research on the intervention of ACLF disease process, and summarizes its potential significance in the treatment of ACLF. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. The Synthesis and Pharmacokinetics of a Novel Liver-Targeting Cholic Acid-Conjugated Carboplatin in Rats.
- Author
-
Lan, Yinyin, Han, Fuguo, Gao, Anli, Fan, Xuemei, Hao, Yanli, Wang, Zhao, Liu, Weiping, Jiang, Jing, and Liu, Qingfei
- Subjects
INDUCTIVELY coupled plasma mass spectrometry ,LIVER cancer ,INTRAVENOUS therapy ,CHOLIC acid ,CANCER cells ,LIVER cells - Abstract
A novel cholic acid-conjugated carboplatin (CP-CA) is developed as a liver-targeting prodrug of carboplatin (CP) for liver cancer. Instead of using CP as a raw material, CP-CA was synthesized simultaneously. This paper is focused on the comparison of CP-CA and CP with respect to their pharmacokinetic (PK) and tissue distribution profiles in rats after their intravenous administration. Additionally, their uptake by human liver tumor cell Huh7 and normal human liver cell HL7702 are investigated. The inductively coupled plasma mass spectrometry (ICP-MS) method is applied for the determination of platinum in plasma, tissues, and cells. The PK results show that both the AUC
0–t and AUC0–∞ data on Pt for CP-CA are significantly higher than those for CP (p < 0.01), indicating that the plasma exposure of CP-CA is significantly higher than that of CP. The CL1 , Vd1 , and Vd2 data on Pt for CP-CA are significantly lower than those for CP (p < 0.01), while the MRT0–t is significantly higher (p < 0.01), which is possibly related to a higher PPBR, and can strongly support the higher AUC0–t and AUC0–∞ of Pt for CP-CA compared to for CP. The tissue distribution results show that CP-CA is mainly distributed and accumulated in the liver after its intravenous administration to rats, revealing its liver-targeting profile. Compared to CP, CP-CA is more easily taken up by human liver cancer cells and normal human liver cells. The results suggest that CP-CA has a potential for further development as a new prodrug specific to liver cancer. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
6. Global research trends and hotspots for leukocyte cell-derived chemotaxin-2 from the past to 2023: a combined bibliometric review.
- Author
-
Wei Liu, Qin Wang, Jianishaya Yeerlan, Yirui Yan, Luke Xu, Cui Jia, Xinlian Liu, and Lushun Zhang
- Subjects
HEPATIC fibrosis ,LEUCOCYTES ,LIVER cells ,BIBLIOMETRICS ,WEB databases ,BILIARY atresia - Abstract
Leukocyte cell-derived chemotaxin-2 (LECT2) is an important cytokine synthesized by liver. Significant research interest is stimulated by its crucial involvement in inflammatory response, immune regulation, disease occurrence and development. However, bibliometric study on LECT2 is lacking. In order to comprehend the function and operation of LECT2 in human illnesses, we examined pertinent studies on LECT2 investigation in the Web of Science database, followed by utilizing CiteSpace, VOSview, and Scimago Graphica for assessing the yearly quantity of papers, countries/regions involved, establishments, authors, publications, citations, and key terms. Then we summarized the current research hotspots in this field. Our study found that the literature related to LECT2 has a fluctuating upward trend. "Angiogenesis", "ALECT2", "diagnosis", and "biliary atresia" are the current investigative frontiers. Our findings indicated that liver diseases (e.g. liver fibrosis and hepatic cell carcinoma), systemic inflammatory disease, and amyloidosis are the current research focus of LECT2. The current LECT2 research outcomes are not exceptional. We hope to promote the scientific research of LECT2 and exploit its potential for clinical diagnosis and treatment of related diseases through a comprehensive bibliometric review. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Patrinia villosa (Thunb.) Juss alleviates CCL4-induced acute liver injury by restoring bile acid levels and inhibiting apoptosis/autophagy.
- Author
-
Ji-Feng Ye, Wei Liu, Qishu Hou, Shu-Qi Bai, Zheng Xiang, Jiaqi Wang, and Liman Qiao
- Subjects
BILE acids ,FARNESOID X receptor ,LIVER injuries ,AUTOPHAGY ,APOPTOSIS ,HEMATOXYLIN & eosin staining ,LIVER cells ,LIVER - Abstract
Background: Patrinia villosa (Thunb.) Juss is one of the plant resources of the famous traditional Chinese medicine "Bai jiang cao (herba patriniae)," and it is considered to function at the liver meridian, thereby treating diseases of the liver as demonstrated by the traditional theory of TCM. Unfortunately, the therapeutic mechanism of the whole plant of PV is so far unknown. Method: UPLC QTOF-MS/MS was used to analyze the profile of PV. Male Sprague-Dawley rats were categorized into five groups, and PV groups (125 and 375mg/kg) were administered by oral gavage for seven consecutive days. The model of liver injury was induced by intraperitoneal injection of 40% CCl
4 oil solution. H&E staining was performed for histological evaluation. The ELISA method was used to assess the serumlevel of ALT, AST, and T-BIL. Serum and liver bile acid (BA) profiling was analyzed by LC-MS/MS. TUNEL-stained liver sections were used to monitor apoptosis caused by CCl4 . HepG2 cells were used to detect autophagy caused by CCl4 . Results: A total of 16 compounds were identified from the 70% methanol extract of PV. PV (125 and 375 mg/kg) could reverse the ectopic overexpression of AST, ALT, and T-BIL caused by CCl4 administration. H&E staining indicated that PV (125 and 375 mg/kg) could reduce the infiltration of inflammatory cells and restore liver tissue and hepatocyte structures. Six bile acids, including DCA, HDCA, GCA, TCA, TCDCA, and TUDCA, were significantly altered both in the serum and liver tissue after CCl4 administration, and the level of all these six bile acids was restored by PV treatment. Moreover, PV inhibited apoptosis caused by CCl4 stimulation in liver tissue and suppressed autophagy in HepG2 cells treated with CCl4 . Conclusion: The results in this paper for the first time reveal the alteration of the bile acid profile in CCl4 -induced liver injury and demonstrate that inhibiting apoptosis and autophagy was involved in P. villosa-elicited liver protection, providing a scientific basis for the clinical utilization of P. villosa as a natural hepatic protective agent. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
8. GDF15: Immunomodulatory Role in Hepatocellular Carcinoma Pathogenesis and Therapeutic Implications.
- Author
-
Du, Yi-Ning and Zhao, Jin-Wei
- Subjects
GROWTH differentiation factors ,HEPATIC fibrosis ,FATTY liver ,PROGNOSIS ,LIVER cells ,HEPATOCELLULAR carcinoma - Abstract
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths globally and the sixth most common cancer worldwide. Evidence shows that growth differentiation factor 15 (GDF15) contributes to hepatocarcinogenesis through various mechanisms. This paper reviews the latest insights into the role of GDF15 in the development of HCC, its role in the immune microenvironment of HCC, and its molecular mechanisms in metabolic dysfunction associated steatohepatitis (MASH) and metabolic associated fatty liver disease (MAFLD)-related HCC. Additionally, as a serum biomarker for HCC, diagnostic and prognostic value of GDF15 for HCC is summarized. The article elaborates on the immunological effects of GDF15, elucidating its effects on hepatic stellate cells (HSCs), liver fibrosis, as well as its role in HCC metastasis and tumor angiogenesis, and its interactions with anticancer drugs. Based on the impact of GDF15 on the immune response in HCC, future research should identify its signaling pathways, affected immune cells, and tumor microenvironment interactions. Clinical studies correlating GDF15 levels with patient outcomes can aid personalized treatment. Additionally, exploring GDF15-targeted therapies with immunotherapies could improve anti-tumor responses and patient outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Molecular Mechanisms in Tumorigenesis of Hepatocellular Carcinoma and in Target Treatments—An Overview.
- Author
-
Szilveszter, Raluca-Margit, Muntean, Mara, and Florea, Adrian
- Subjects
HEPATOCELLULAR carcinoma ,CELL anatomy ,CANCER stem cells ,EXTRACELLULAR matrix ,LIVER cells ,MOLECULAR biology - Abstract
Hepatocellular carcinoma is the most common primary malignancy of the liver, with hepatocellular differentiation. It is ranked sixth among the most common cancers worldwide and is the third leading cause of cancer-related deaths. The most important etiological factors discussed here are viral infection (HBV, HCV), exposure to aflatoxin B1, metabolic syndrome, and obesity (as an independent factor). Directly or indirectly, they induce chromosomal aberrations, mutations, and epigenetic changes in specific genes involved in intracellular signaling pathways, responsible for synthesis of growth factors, cell proliferation, differentiation, survival, the metastasis process (including the epithelial–mesenchymal transition and the expression of adhesion molecules), and angiogenesis. All these disrupted molecular mechanisms contribute to hepatocarcinogenesis. Furthermore, equally important is the interaction between tumor cells and the components of the tumor microenvironment: inflammatory cells and macrophages—predominantly with a pro-tumoral role—hepatic stellate cells, tumor-associated fibroblasts, cancer stem cells, extracellular vesicles, and the extracellular matrix. In this paper, we reviewed the molecular biology of hepatocellular carcinoma and the intricate mechanisms involved in hepatocarcinogenesis, and we highlighted how certain signaling pathways can be pharmacologically influenced at various levels with specific molecules. Additionally, we mentioned several examples of recent clinical trials and briefly described the current treatment protocol according to the NCCN guidelines. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Effect of Statin Lipophilicity on the Proliferation of Hepatocellular Carcinoma Cells.
- Author
-
Glebavičiūtė, Goda, Vijaya, Akshay Kumar, and Preta, Giulio
- Subjects
HEPATOCELLULAR carcinoma ,STATINS (Cardiovascular agents) ,CANCER cell growth ,LIPOPHILICITY ,BLOOD cholesterol ,LIVER cells ,CELL death - Abstract
Simple Summary: This study examines how statins, which are drugs commonly used to lower cholesterol, affect the growth of liver cancer cells. Statins can be either lipophilic (lipid-soluble) or hydrophilic (water-soluble), and this characteristic influences how they enter cells. In our research, we compared the effects of lipophilic simvastatin and hydrophilic pravastatin. We found that simvastatin significantly reduces cancer cell growth and increases cell death depending on the dosage and duration of treatment. In contrast, pravastatin, due to its limited uptake, has a minimal impact on cancer cells. These findings suggest that the type of statin used could be crucial in cancer treatment, potentially offering better outcomes for patients with liver cancer. The HMG-CoA reductase inhibitors, statins, are drugs used globally for lowering the level of cholesterol in the blood. Different clinical studies of statins in cancer patients have indicated a decrease in cancer mortality, particularly in patients using lipophilic statins compared to those on hydrophilic statins. In this paper, we selected two structurally different statins (simvastatin and pravastatin) with different lipophilicities and investigated their effects on the proliferation and apoptosis of hepatocellular carcinoma cells. Lipophilic simvastatin highly influences cancer cell growth and survival in a time- and concentration-dependent manner, while pravastatin, due to its hydrophilic structure and limited cellular uptake, showed minimal cytotoxic effects. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Hepatocellular Carcinoma and the Multifaceted Relationship with Its Microenvironment: Attacking the Hepatocellular Carcinoma Defensive Fortress.
- Author
-
Galasso, Linda, Cerrito, Lucia, Maccauro, Valeria, Termite, Fabrizio, Ainora, Maria Elena, Gasbarrini, Antonio, and Zocco, Maria Assunta
- Subjects
DRUG resistance in cancer cells ,CIRRHOSIS of the liver ,DECISION making ,TREATMENT effectiveness ,IMMUNE system ,LIVER cells ,GROWTH factors ,EXTRACELLULAR space ,CYTOKINES ,HEPATOCELLULAR carcinoma ,LIVER blood-vessels - Abstract
Simple Summary: The microenvironment of hepatocellular carcinoma is a really complex milieu, containing a wide variety of cells with specific tasks, belonging to both the mesenchimal and immunitary systems, the extracellular matrix, growth factors, proinflammatory cytokines, and translocated bacterial products. This intricate environment represents a source of potential targets in order to establish a wide and multitask therapeutic strategy for hepatocellular carcinoma. Hepatocellular carcinoma is a malignant tumor that originates from hepatocytes in an inflammatory substrate due to different degrees of liver fibrosis up to cirrhosis. In recent years, there has been growing interest in the role played by the complex interrelationship between hepatocellular carcinoma and its microenvironment, capable of influencing tumourigenesis, neoplastic growth, and its progression or even inhibition. The microenvironment is made up of an intricate network of mesenchymal cells, immune system cells, extracellular matrix, and growth factors, as well as proinflammatory cytokines and translocated bacterial products coming from the intestinal microenvironment via the enterohepatic circulation. The aim of this paper is to review the role of the HCC microenvironment and describe the possible implications in the choice of the most appropriate therapeutic scheme in the prediction of tumor response or resistance to currently applied treatments and in the possible development of future therapeutic perspectives, in order to circumvent resistance and break down the tumor's defensive fort. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Madelung's Disease Evolving to Liposarcoma: An Uncommon Encounter.
- Author
-
Lungu, Mihaiela, Oprea, Violeta Diana, Stoleriu, Gabriela, Ionescu, Ana-Maria, Zaharia, Andrei Lucian, Croitoru, Ana, Stan, Bianca, and Niculet, Elena
- Subjects
LIPOSARCOMA ,EMERGENCY medicine ,ADIPOSE tissues ,LIVER metastasis ,FAT cells ,LIVER cells - Abstract
(1) Background: Madelung's disease—known also as Benign Symmetric Adenolipomatosis (BSA) or Multiple Symmetric Lipomatosis (MSL), is a rare subcutaneous tissue disease characterized by the proliferation of non-encapsulated fat tissue with mature adipocytes. Patients develop symmetrical fatty deposits of varying sizes, (located particularly around the neck, shoulders, upper and middle back, arms, abdomen, and thighs), having clinical, esthetic, and psychiatric repercussions. (2) Methods: We report a case diagnosed with BSA upon admission to the Neurological and Internal Medicine Departments of the Emergency Clinical Hospital of Galati. (3) Results: This patient developed compressive phenomena and liposarcoma with liver metastasis, followed by death shortly after hospital presentation. The histopathology examination confirmed right latero-cervical liposarcoma and round cell hepatic metastasis. The specific metabolic ethiopathogenic mechanism has not been elucidated, but the adipocytes of BSA are different from normal cells in proliferation, hormonal regulation, and mitochondrial activity; a rare mitochondrial gene mutation, together with other interacting genetic or non-genetic factors, have been considered in recent studies. A thorough literature search identified only three cases reporting malignant tumors in BSA patients. (4) Conclusions: The goal of our paper is to present this rare case in the oncogenic synergism of two tumors. In the management of this BSA disorder, possible malignant transformation should be considered, although only scarce evidence was found supporting this. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Exploration of the Delivery of Oncolytic Newcastle Disease Virus by Gelatin Methacryloyl Microneedles.
- Author
-
Zhang, Qiang, Na, Jintong, Liu, Xiyu, and He, Jian
- Subjects
NEWCASTLE disease virus ,GELATIN ,ZETA potential ,IMMUNOFLUORESCENCE ,VIRUS-like particles ,AGGLOMERATION (Materials) ,PHOTOCROSSLINKING ,LIVER cells - Abstract
Oncolytic Newcastle disease virus is a new type of cancer immunotherapy drug. This paper proposes a scheme for delivering oncolytic viruses using hydrogel microneedles. Gelatin methacryloyl (GelMA) was synthesized by chemical grafting, and GelMA microneedles encapsulating oncolytic Newcastle disease virus (NDV) were prepared by micro-molding and photocrosslinking. The release and expression of NDV were tested by immunofluorescence and hemagglutination experiments. The experiments proved that GelMA was successfully synthesized and had hydrogel characteristics. NDV was evenly dispersed in the allantoic fluid without agglomeration, showing a characteristic virus morphology. NDV particle size was 257.4 ± 1.4 nm, zeta potential was −13.8 ± 0.5 mV, virus titer TCID50 was 10
7.5 /mL, and PFU was 2 × 107 /mL, which had a selective killing effect on human liver cancer cells in a dose and time-dependent manner. The NDV@GelMA microneedles were arranged in an orderly cone array, with uniform height and complete needle shape. The distribution of virus-like particles was observed on the surface. GelMA microneedles could successfully penetrate 5% agarose gel and nude mouse skin. Optimal preparation conditions were freeze-drying. We successfully prepared GelMA hydrogel microneedles containing NDV, which could effectively encapsulate NDV but did not detect the release of NDV. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
14. Gliosis induction on locus coeruleus in a living liver donor experimental model: A brief review.
- Author
-
Barrientos-Bonilla, Abril Alondra, Pensado-Guevara, Paola Belem, Nadella, Rasajna, Sánchez-García, Aurora del Carmen, Zavala-Flores, Laura Mireya, and Hernandez-Baltazar, Daniel
- Subjects
LOCUS coeruleus ,LIVER cells ,DOPAMINERGIC neurons ,GLIOSIS ,URINARY tract infections - Abstract
Living Donor Liver Transplantation (LDLT) is a promising approach to treating end-stage liver diseases, however, some post-operatory complications such as pneumonia, bacteremia, urinary tract infections, and hepatic dysfunction have been reported. In murine models using partial hepatectomy (PHx), a model that emulates LDLT, it has been determined that the synthesis of hepatic cell proliferation factors that are associated with noradrenaline synthesis are produced in locus coeruleus (LC). In addition, studies have shown that PHx decreases GABA and 5-HT2A receptors, promotes loss of dendritic spines, and favors microgliosis in rat hippocampus. The GABA and serotonin-altered circuits suggest that catecholaminergic neurons such as dopamine and noradrenaline neurons, which are highly susceptible to cellular stress, can also be damaged. To understand post-transplant affections and to perform well-controlled studies it is necessary to know the potential causes that explain as a liver surgical procedure can produce brain damage. In this paper, we review several cellular processes that could induce gliosis in LC after rat PHx. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Size-related variability of oxygen consumption rates in individual human hepatic cells.
- Author
-
Botte, Ermes, Cui, Yuan, Magliaro, Chiara, Tenje, Maria, Koren, Klaus, Rinaldo, Andrea, Stocker, Roman, Behrendt, Lars, and Ahluwalia, Arti
- Subjects
OXYGEN consumption ,LIVER cells ,AEROBIC capacity ,CELL culture ,CELL size ,CELL populations - Abstract
Accurate descriptions of the variability in single-cell oxygen consumption and its size-dependency are key to establishing more robust tissue models. By combining microfabricated devices with multiparameter identification algorithms, we demonstrate that single human hepatocytes exhibit an oxygen level-dependent consumption rate and that their maximal oxygen consumption rate is significantly lower than that of typical hepatic cell cultures. Moreover, we found that clusters of two or more cells competing for a limited oxygen supply reduced their maximal consumption rate, highlighting their ability to adapt to local resource availability and the presence of nearby cells. We used our approach to characterize the covariance of size and oxygen consumption rate within a cell population, showing that size matters, since oxygen metabolism covaries lognormally with cell size. Our study paves the way for linking the metabolic activity of single human hepatocytes to their tissue- or organ-level metabolism and describing its size-related variability through scaling laws. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Optimized microfluidic formulation and organic excipients for improved lipid nanoparticle mediated genome editing.
- Author
-
Palanki, Rohan, Han, Emily L., Murray, Amanda M., Maganti, Rohin, Tang, Sophia, Swingle, Kelsey L., Kim, Dongyoon, Yamagata, Hannah, Safford, Hannah C., Mrksich, Kaitlin, Peranteau, William H., and Mitchell, Michael J.
- Subjects
GENOME editing ,NUCLEIC acids ,LIVER cells ,MESSENGER RNA ,CRISPRS - Abstract
mRNA-based gene editing platforms have tremendous promise in the treatment of genetic diseases. However, for this potential to be realized in vivo, these nucleic acid cargos must be delivered safely and effectively to cells of interest. Ionizable lipid nanoparticles (LNPs), the most clinically advanced non-viral RNA delivery system, have been well-studied for the delivery of mRNA but have not been systematically optimized for the delivery of mRNA-based CRISPR-Cas9 platforms. In this study, we investigated the effect of microfluidic and lipid excipient parameters on LNP gene editing efficacy. Through in vitro screening in liver cells, we discovered distinct trends in delivery based on phospholipid, cholesterol, and lipid-PEG structure in LNP formulations. Combination of top-performing lipid excipients produced an LNP formulation that resulted in 3-fold greater gene editing in vitro and facilitated 3-fold greater reduction of a therapeutically-relevant protein in vivo relative to the unoptimized LNP formulation. Thus, systematic optimization of LNP formulation parameters revealed a novel LNP formulation that has strong potential for delivery of gene editors to the liver to treat metabolic disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Hepatic cell junctions: Pulling a double‐duty.
- Author
-
Van Campenhout, Raf and Vinken, Mathieu
- Subjects
- *
CELL junctions , *ADHERENS junctions , *TIGHT junctions , *LIVER cells , *LIFE cycles (Biology) - Abstract
Cell junctions, including anchoring, occluding and communicating junctions, play an indispensable role in the structural and functional organization of multicellular tissues, including in liver. Specifically, hepatic cell junctions mediate intercellular adhesion and communication between liver cells. The establishment of the hepatic cell junction network is a prerequisite for normal liver functioning. Hepatic cell junctions indeed support liver‐specific features and control essential aspects of the hepatic life cycle. This review paper summarizes the role of cell junctions and their components in relation to liver physiology, thereby also discussing their involvement in hepatic dysfunctionality, including liver disease and toxicity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Deciphering hepatoma cell resistance to tyrosine kinase inhibitors: insights from a Liver-on-a-Chip model unveiling tumor endothelial cell mechanisms.
- Author
-
Poddar, Madhu Shree, Chu, Yu-De, Yeh, Chau-Ting, and Liu, Cheng-Hsien
- Subjects
PROTEIN-tyrosine kinase inhibitors ,ENDOTHELIAL cells ,HEPATOCELLULAR carcinoma ,LIVER cells ,LIVER tumors - Abstract
Liver cancer represents a significant global burden in terms of cancer-related mortality, with resistance to anti-angiogenic drugs such as Sorafenib and Lenvatinib presenting a formidable challenge. Tumor angiogenesis, characterized by the formation of new blood vessels within tumors, plays a pivotal role in cancer progression and metastasis. Tumor endothelial cells, specialized endothelial cells lining tumor blood vessels, exhibit unique phenotypic and functional traits that drive aberrant vessel formation and contribute to therapy resistance. CD105, a cell-surface glycoprotein that is highly expressed on endothelial cells during angiogenesis, including tumor endothelial cells, regulates endothelial cell proliferation, migration, and vessel formation by modulating transforming growth factor-beta (TGF-β) signaling pathways. Elevated CD105 expression on tumor endothelial cells correlates with increased angiogenic activity and poor prognosis in cancer patients. Targeting CD105 with antibodies presents a promising strategy to inhibit tumor angiogenesis and disrupt tumor vasculature, offering potential therapeutic benefits by interfering with the tumor microenvironment and inhibiting its progression. This study investigates tumor angiogenesis through a three-dimensional (3D) microfluidic co-culture system incorporating endothelial cells and hepatocellular carcinoma (HCC) cells. The primary focus is on the role of CD105 expression within the liver tumor microenvironment and its contribution to increased chemoresistance. Additionally, this research examines the influence of CD105 expression on the efficacy of tyrosine kinase inhibitors (TKIs) and its pivotal function in facilitating angiogenesis in liver tumors. The proposed microfluidic chip model investigates liver cancer cell interactions within a microfluidic chip model designed to simulate aspects of liver tumor angiogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Microvesicles from quiescent and TGF-β1 stimulated hepatic stellate cells: Divergent impact on hepatic vascular injury.
- Author
-
Xie, Jianlong, Ye, Zhirong, Xu, Xiaobing, Chang, Anzhi, Yang, Ziyi, Wu, Qin, Pan, Qunwen, Wang, Yan, Chen, Yanyu, Ma, Xiaotang, and Miao, Huilai
- Subjects
LIVER cells ,VASCULAR endothelial cells ,EXTRACELLULAR vesicles ,HEPATIC fibrosis ,UMBILICAL veins ,PROTEIN expression - Abstract
Background: This study evaluated the effect of microvesicles(MVs) from quiescent and TGF-β1 stimulated hepatic stellate cells (HSC-MVs, TGF-β1HSC-MVs) on H
2 O2 -induced human umbilical vein endothelial cells (HUVECs) injury and CCl4 -induced rat hepatic vascular injury. Methods: HUVECs were exposed to hydrogen peroxide (H2 O2 ) to establish a model for vascular endothelial cell injury. HSC-MVs or TGF-β1HSC-MVs were co-cultured with H2 O2 -treated HUVECs, respectively. Indicators including cell survival rate, apoptosis rate, oxidative stress, migration, invasion, and angiogenesis were measured. Simultaneously, the expression of proteins such as PI3K, AKT, MEK1+MEK2, ERK1+ERK2, VEGF, eNOS, and CXCR4 was assessed, along with activated caspase-3. SD rats were intraperitoneally injected with CCl4 twice a week for 10 weeks to induce liver injury models. HSC-MVs or TGF-β1HSC-MVs were injected into the tail vein of rats. Liver and hepatic vascular damage were also detected. Results: In H2 O2 -treated HUVECs, HSC-MVs increased cell viability, reduced cytotoxicity and apoptosis, improved oxidative stress, migration, and angiogenesis, and upregulated protein expression of PI3K, AKT, MEK1/2, ERK1/2, VEGF, eNOS, and CXCR4. Conversely,TGF-β1 HSC-MVs exhibited opposite effects. CCl4 - induced rat hepatic injury model, HSC-MVs reduced the release of ALT and AST, hepatic inflammation, fatty deformation, and liver fibrosis. HSC-MVs also downregulated the protein expression of CD31 and CD34. Conversely, TGF-β1HSC-MVs demonstrated opposite effects. Conclusion: HSC-MVs demonstrated a protective effect on H2 O2 -treated HUVECs and CCl4 -induced rat hepatic injury, while TGF-β1HSC-MVs had an aggravating effect. The effects of MVs involve PI3K/AKT/VEGF, CXCR4, and MEK/ERK/eNOS pathways. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
20. Better 90 Minutes Late than Never: Differential Diagnosis on MRI Scanning in a Case of Hepatic Angiosarcoma.
- Author
-
Albu, Teodora Anca and Iacob, Nicoleta
- Subjects
DIFFERENTIAL diagnosis ,MAGNETIC resonance imaging ,ANGIOSARCOMA ,LIVER cells ,CONTRAST-enhanced magnetic resonance imaging - Abstract
Primary hepatic angiosarcoma (PHA) is a rare liver malignancy with few studies describing its radiological characteristics. This article aims to assess the imaging features of each of the multiple delayed contrast-enhanced magnetic resonance imaging (MRI) scans, in addition to the conventional MRI protocol, in a patient with PHA. Standard MRI sequences and a liver protocol were used in the examination of a 71 year-old male with pathologically proven PHA after current imaging evaluation. In addition, the patient underwent transversal and coronal MRI T1-weighted scans at 10 min, 20 min and 90 min after intravenous (IV) administration of gadobenatedimeglumine (Gd-BOPTA). The PHA revealed a variable appearance on MRI, with classic imaging being insufficient in making a reliable diagnosis. Lesions have increased vascularity, which translates into increased IV contrast uptake in the MRI arterial phase, showing progressive and globular enhancement in the portal and parenchymatous phases. On delayed scans, at 10 min after IV administration, the lesions maintained no washout, but slightly began to washout at 20 min post-contrast. However, in the hepatobiliary phase (90 min post-contrast injection), on an MRI T1-weighted sequence, PHA lesions were hypointense, suggesting the absence of hepatocytes, thus indicating high-grade malignancy. This approach proved the conclusion that in a patient with PHA, an extra MRI T1-weighted scan at 90 min post-gadobenatedimeglumine injection can provide helpful information in differential diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Role and uptake of metal-based nanoconstructs as targeted therapeutic carriers for rheumatoid arthritis.
- Author
-
Dwivedi, Shradha Devi, Bhoi, Anita, Pradhan, Madhulika, Sahu, Keshav Kant, Singh, Deependra, and Singh, Manju Rawat
- Subjects
- *
RHEUMATOID arthritis , *LIVER cells , *ANTI-inflammatory agents , *REDUCTASES , *TITANIUM oxides , *OXIDATIVE stress , *SELENIUM - Abstract
Rheumatoid Arthritis (RA) is a chronic autoimmune systemic inflammatory disease that affects the joints and other vital organs and diminishes the quality of life. The current developments and innovative treatment options have significantly slowed disease progression and improved their quality of life. Medicaments can be delivered to the inflamed synovium via nanoparticle systems, minimizing systemic and undesirable side effects. Numerous nanoparticles such as polymeric, liposomal, and metallic nanoparticles reported are impending as a good carrier with therapeutic properties. Other issues to be considered along are nontoxicity, nanosize, charge, optical property, and ease of high surface functionalization that make them suitable carriers for drug delivery. Metallic nanoparticles (MNPs) (such as silver, gold, zinc, iron, titanium oxide, and selenium) not only act as good carrier with desired optical property, and high surface modification ability but also have their own therapeutical potential such as anti-oxidant, anti-inflammatory, and anti-arthritic properties, making them one of the most promising options for RA treatment. Regardless, cellular uptake of MNPs is one of the most significant criterions for targeting the medication. This paper discusses the numerous interactions of nanoparticles with cells, as well as cellular uptake of NPs. This review provides the mechanistic overview on MNPs involved in RA therapies and regulation anti-arthritis response such as ability to reduce oxidative stress, suppressing the release of proinflammatory cytokines and expression of LPS induced COX-2, and modulation of MAPK and PI3K pathways in Kuppfer cells and hepatic stellate cells. Despite of that MNPs have also ability to regulates enzymes like glutathione peroxidases (GPxs), thioredoxin reductases (TrxRs) and act as an anti-inflammatory agent. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Photocytotoxic kinetically stable ruthenium(II)-N,N-donor polypyridyl complexes of oxalate with anticancer activity against HepG2 liver cancer cells.
- Author
-
Sayala, Juhi, Srivastava, Ekta, Kumar, Priyaranjan, Shukla, Nitin, Kumar, Ashok, and Patra, Ashis K.
- Subjects
LIVER cancer ,LIVER cells ,OXALATES ,CANCER cells ,GREEN light ,TRYPTOPHAN - Abstract
Liver cancer is one of the leading causes of death that motivating scientists worldwide to synthesize novel chemotherapeutics. Ru(II)-polypyridyl complexes are extensively studied for possible therapeutic and cellular applications due to their tunable coordination chemistry, structural diversity, ligand-exchange kinetics, accessible redox states, and rich photophysical or photochemical properties. Herein, we have synthesized a series of Ru(II) polypyridyl complexes [Ru
II (N^N)2 (ox)] (1–3), where ox is oxalate (C2 O4 2− ) and N^N is 1,10-phenanthroline (phen) (1), dipyrido[3,2-d:2′,3′-f]quinoxaline (dpq) (2), and dipyrido[3,2,-a:2′,3′-c]phenazine (dppz) (3). Oxalate (ox2− ) was opted as a bioactive dioxo ligand to prevent facile hydrolysis in aqueous media, thereby increasing the stability of the Ru(II)-polypyridyl complexes in physiological media. We thoroughly characterized all the complexes using ESI-MS, FT-IR, UV-vis, and1 H NMR spectroscopy and other physicochemical methods. The complexes were stable under physiological conditions and under low-energy green LED light (λirr = 530 nm). However, the photoirradiation of complexes resulted in the efficient generation of singlet oxygen (1 O2 ) as a major reactive oxygen species (ROS). The role of the extended aromatic conjugation of the N^N-donor ligands in the complexes was demonstrated by their binding propensities with CT-DNA and bovine serum albumin (BSA). Both DNA intercalation and groove binding were evidenced, while tryptophan (Trp) and tyrosine (Tyr) binding site preferences were revealed from the synchronous fluorescence spectra (SFS) of BSA. The cytotoxic profiling of the complexes performed on hepatocellular carcinoma cells (HepG2) in the dark and in the presence of green light indicated their dose-dependent cytotoxicity. The [RuII (N^N)2 (ox)] complexes exhibited enhanced photocytotoxicity mediated by efficient generation of cytotoxic1 O2 and effective interaction with DNA. All the complexes were internalized by the HepG2 liver cancer cells efficiently and localized to the cytoplasm and nucleus. The complexes exhibited potent anti-proliferative, anti-clonogenic, and anti-migratory effects on the cancer cells, suggesting their potential for therapeutic applications. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
23. An endoplasmic reticulum-targeted fluorescent probe for ratiometric tracking of endogenous SO2 derivatives.
- Author
-
Yan, Yehao, Gong, Weilei, Li, Ruiji, Sun, Jiannan, Wang, Hua, He, Xiaoying, and Si, Yanmei
- Subjects
FLUORESCENT probes ,LIVER cells ,STOKES shift ,ENDOPLASMIC reticulum ,LIVER cancer - Abstract
A novel fluorescent probe (JSS-1) for endogenous SO
2 derivatives was developed by using 1,8-naphthalimide and malononitrile dyes on the basis of FRET and the ICT mechanism. JSS-1 possessed excellent photo-stability, deep-red emission signal, large Stokes shift and broad emission window gap. Additionally, it displayed various superiorities in sensing SO2 derivatives, including low sensing limit, high sensitivity and selectivity. Significantly, JSS-1 was successfully employed to track endogenous SO2 derivatives in the endoplasmic reticulum with a high co-localization coefficient of 0.93, and could even be used for the recognition of liver cancer cells. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
24. A temperature-sensitive HA-anchoring supramolecular nanocarrier for targeted delivery of the anti-liver cancer drug doxorubicin.
- Author
-
Wang, Hong-Xia, Li, Bi-Lian, Yang, Jian-Mei, He, Jun-Nan, Wang, Dan-Dan, Liu, Xiao-Qing, Zhao, Yan, and Zhang, Jin
- Subjects
HYALURONIC acid ,ANTINEOPLASTIC agents ,LIVER cells ,LIVER cancer ,CANCER cells ,CELL nuclei ,CISPLATIN ,DOXORUBICIN - Abstract
Supramolecular nanocarriers (NCs) that are capable of responding to stimuli and actively targeting specific cells have garnered significant interest in recent years. However, designing multi-stimuli responsive nanocarriers with active targeting capabilities remains a challenge. To address this issue, we developed a temperature/enzyme dual-stimuli responsive supramolecular nanocarrier (AβCD/HA NC) through the electrostatic interaction between a cationic heptakis-(6-amino-6-deoxy)-β-cyclodextrin (AβCD) and anionic hyaluronic acid (HA). The AβCD/HA NC exhibited temperature/enzyme co-triggered assembly/disassembly behavior, which facilitated the loading, delivery, and release of the first-line anti-liver cancer drug doxorubicin (DOX). The release rate of DOX from the DOX-loaded AβCD/HA NC was found to be 82.4% at T = 45 °C and with the addition of hyaluronidase (HAase). During the uptake studies conducted on SMMC-7721 liver cancer cells, it was observed that the AβCD/HA NC significantly enhances the intracellular uptake of DOX, and the DOX present in the NC can efficiently be delivered to the cell nucleus. The cellular viability assay (MTS) demonstrated that the DOX-loaded NC not only provided a better inhibitory effect on SMMC-7721 liver cancer cells than free DOX and cisplatin, but also exhibited only one-tenth of the cytotoxicity of free DOX in BEAS-2B normal human epithelial cells. Our findings suggest that the AβCD/HA NC holds great promise for the targeted treatment of liver cancer cells. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Click chemistry-based synthesis of new 1,2,3-triazolo-benzoquinoline-3-carbonitriles: anticancer screening and DFT studies.
- Author
-
El Malah, Tamer, Farag, Hanaa, Awad, Hanem M., and Soliman, Hanan A.
- Subjects
RING formation (Chemistry) ,FRONTIER orbitals ,ELECTRIC potential ,LIVER cancer ,LIVER cells ,CANCER cells - Abstract
This study emphasizes the synthesis of a novel series of 1,2,3-triazolo-benzoquinoline-3-carbonitriles by using Cu(I)-catalyzed azide–alkyne cycloaddition known as the click reaction. The reaction of novel acetylenic aryl-benzoquinoline-3-carbonitriles 7–12 with 1-azido-2,5-dimethoxy-4-nitrobenzene 13 afforded the corresponding 1,2,3-triazolo-benzoquinoline-3-carbonitriles 14–19 in good yields. The desired products were examined against different tumor cells such as the human colon (HCT-116), hepatocellular carcinoma (HepG2), human breast adenocarcinoma (MCF-7) and one human healthy cell line (BJ-1) using the LDH assay. Generally, the five compounds (11, 10, 9, 12 and 15, respectively) can be considered good colon anticancer drug candidates as their cytotoxic activities on the colon cancer cells are higher than their cytotoxic activities on the normal cells. In the case of HepG2 human liver cancer cells, compounds 16, 12 and 9 have more potent cytotoxic activities relative to doxorubicin as the standard reference. Supporting the experimental antiproliferative IC
50 of the compounds tested against the cancer cell line, the molecular electrostatic potential (MEP) distribution and frontier molecular orbitals (FMOs) of all compounds have been calculated in the ground state theoretically by the DFT/B3LYP method using the 6-31G(d) basis set. Compounds 10, 15 and 19 showed a chemical softness value of 14.59 eV−1 higher than those of all of the compounds. The highest values of the electrophilicity index were observed in compounds 17, 10, 16 and 15. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
26. Polydiacetylene/lipid-coated red-emissive silica nanorods for the sustained release and ameliorated anticancer efficacy of a Ru(arene) complex bearing piperlongumine natural product.
- Author
-
Ishaniya, Wickneswaran, Sumithaa, Chezhiyan, Subramani, Muthuraman, Karanath-Anilkumar, Aswathy, Munuswamy-Ramanujam, Ganesh, Madan Kumar, Arumugam, Rajendran, Saravanakumar, and Ganeshpandian, Mani
- Subjects
NATURAL products ,ANTINEOPLASTIC agents ,NANORODS ,SILICA nanoparticles ,LIVER cells - Abstract
A suitable drug delivery strategy for metallodrugs is as significant as the strategies adopted for an efficient metallodrug design. In this study, piperlongumine, which is isolated from long pepper, is coordinated with a Ru(II)-p-cymene moiety to obtain an organoruthenated complex containing the natural product (Ru(pip)). The isolated complex shows higher cytotoxicity in MCF-7 breast cancer cells than in THP-1 leukemia and HepG2 liver cancer cells. The IC
50 value of the complex in non-cancerous HEK-239 cells is also almost equal to that in MCF-7 cells. Next, with an aim to modulate the antiproliferative activity of Ru(pip) using a drug delivery strategy, the complex is loaded into mesoporous silica nanorods (MSNRs), which have a higher surface area than spherical silica nanoparticles. Furthermore, the outer surface of the loaded nanorods is covered with a polydiacetylene-lipid (PL) hybrid bilayer. Given the unique optical properties of polydiacetylene, the PL coating modifies non-fluorescent MSNRs into red-emissive particles (PL-Ru(pip)@MSNRs), which can be useful for diagnostic applications. The release profile studies reveal that the ene-yne conjugation in the PL coating ensures the sustained release of the complex from nanoparticles in both physiological and simulated cancer cell media. While Ru(pip) exhibits both necrotic and apoptotic modes of cell death, PL-Ru(pip)@MSNRs preferably induce the apoptotic mode of cell death in MCF-7 and THP-1 cells. Also, the nanoformulation exhibits a higher percentage of cell cycle arrest in the G0/G1 phase than Ru(pip), as measured by flow cytometry analysis. In contrast, the in vitro antioxidant potency of the complex is decreased after being loaded into PL-coated silica nanoparticles. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
27. Silencing of GDF11 suppresses hepatocyte apoptosis to relieve LPS/D‐GalN acute liver failure.
- Author
-
Zhou, Rongsheng, Li, Shuang, Wang, Qun, Bi, Yang, Li, Xiaogang, and Wang, Qiang
- Subjects
LIVER failure ,INHIBITION of cellular proliferation ,RAPAMYCIN ,LIVER cells ,ANIMAL experimentation ,APOPTOSIS - Abstract
In this paper, we generated a short hairpin RNA growth differentiation factor‐11 (sh‐GDF11) and evaluated the effects of sh‐GDF11 on the pathogenesis of acute liver failure (ALF) in vitro and in vivo. Through bioinformatics study, the key gene related to ALF was assayed. Lipopolysaccharide (LPS) and D‐galactoamine (D‐GalN) were applied to establish the mouse model of LPS/D‐GalN‐induced liver injury, and TNF‐α and D‐Gal were used to construct an in vitro cell model, followed by treatment of sh‐GDF11 for analysis of liver cell proliferation. Bioinformatics analysis showed that the protective effect of sh‐GDF11 on ALF may be mediated by phosphatidylinositol‐3‐kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway. The results of in vitro study found that sh‐GDF11 could promote cell proliferation and inhibit death by blocking the PI3K/Akt/mTOR signaling pathway. In vivo animal experiments further confirmed that sh‐GDF11 could suppress hepatocyte apoptosis by inhibiting the PI3K/Akt/mTOR signaling pathway. sh‐GDF11 relieved LPS/D‐GalN‐induced ALF by blocking the PI3K/Akt/mTOR signaling pathway, emphasizing its critical role in LPS/D‐GalN‐induced ALF treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. miR-31 Modulates Liver Cancer HepG2 Cell Apoptosis and Invasion via ROCK1/F-Actin Pathways [Retraction].
- Author
-
Zhang, Xin, Xu, Lan, and Yang, Ting
- Subjects
LIVER cancer ,CANCER cells ,APOPTOSIS ,MITOCHONDRIAL dynamics ,LIVER cells - Abstract
This document is a retraction notice for an article titled "miR-31 Modulates Liver Cancer HepG2 Cell Apoptosis and Invasion via ROCK1/F-Actin Pathways." The authors of the article requested the retraction after concerns were raised about similarities between their data and data from other published articles by unrelated authors. Investigation revealed that images in Figures 3 and 5 of the article were duplicated from these other articles. The authors were unable to provide a satisfactory explanation or data, so the article was retracted to maintain the integrity of the scholarly record. The retracted article will remain online but will be marked as "Retracted." [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
29. Therapeutic potential of ASK1 activators in cancer treatment: Current insights and future directions.
- Author
-
Wang, Bo, Ma, Ying, Zhang, Yue, and Yin, Xunzhe
- Subjects
- *
MITOGEN-activated protein kinases , *HEAT shock proteins , *LIVER cells , *SILVER nanoparticles , *CANCER cells - Abstract
Apoptosis signal-regulated kinase 1 (ASK1) is a member of the mitogen-activated protein kinase kinase (MAP3K) family, whose activation and regulation are intricately associated with apoptosis. ASK1 is activated in response to oxidative stress, among other stimuli, subsequently triggering downstream JNK, p38 MAPK, and mitochondria-dependent apoptotic signaling, which participate in the initiation of tumor cell apoptosis induced by various stimuli. Research has shown that ASK1 plays a crucial role in the apoptosis of lung cancer, breast cancer, and liver cancer cells. Currently, the investigation of effective ASK1 activators is a hot topic in research on tumor cell apoptosis. Synthetic compounds such as human β-defensin, triazolothiazide derivatives and heat shock protein 27 inhibitors; natural compounds such as quercetin, Laminarina japonica polysaccharide-1 peptide and theabrownin; and nanomedicines such as cerium oxide nanoparticles, magnetite FeO nanoparticles and silver nanoparticles can activate ASK1 and induce apoptosis in various tumor cells. This review extensively investigates the roles and activation mechanisms of ASK1, explores its impact on a variety of apoptotic signaling pathways, and discusses the potential therapeutic applications of various ASK1 activators in cancer treatment. In addition, this paper provides an in-depth discussion of the future development of this field and proposes a promising method for further research and clinical progress. [Display omitted] • The activation and regulation of ASK1 are closely related to cell apoptosis. • Activated ASK1 can trigger various downstream apoptotic signaling pathways. • Exploring ASK1 activators is a hot topic in tumor cell apoptosis research. • ASK1 activators include synthetic compounds, natural compounds, and nanomedicines. • ASK1 activators have great potential for the treatment of malignant tumors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. miR-743b-3p promotes hepatic lipogenesis via branched-chain amino acids (BCAA) metabolism by targeting PPM1K in aged mice.
- Author
-
Lu, Ting, Zheng, Ying, Chen, Xiaoling, Lin, Zhiyong, Liu, Chaoqi, and Yuan, Chengfu
- Subjects
- *
BIOLOGICAL models , *IN vitro studies , *LIPID metabolism disorders , *MICRORNA , *CELLULAR aging , *DESCRIPTIVE statistics , *MICE , *BIOINFORMATICS , *LIVER cells , *BRANCHED chain amino acids , *GENETIC disorders , *AGING , *ANIMAL experimentation , *LIVER , *SEQUENCE analysis - Abstract
• In this paper, we found that senescent mice develop pathologies such as obesity lipid metabolism disorders. • The expression of miR-743b-3p was elevated in senescent mice, which inhibited the expression of PPM1K. • MiR-743b-3p regulates BCAA levels in senescent hepatocytes by targeting PPM1K causing abnormal lipid deposition. Lipid metabolism disorders appear to play an important role in the ageing process, thus understanding the cellular and molecular mechanisms underlying the association of ageing with elevated vulnerability to lipid metabolism related diseases is crucial towards promoting quality of life in old age. MicroRNAs (miRNAs) have emerged as crucial regulators of lipid metabolism, and some miRNAs have key roles in ageing. In this study, we investigated changes in liver lipid metabolism of ageing mice and the mechanisms of the altered expression of miRNAs in the ageing liver which contributes to the age-dependent increase in lipid synthesis. Here we found that miR-743b-3p was higher expressed in the liver tissues of ageing mice through the small RNA sequencing and bioinformatics analysis, and its target PPM1K was predicted and confirmed the target relationship of miR-743b-3p with PPM1K in the aged mouse liver tissues and the cultured senescent hepatocytes in vitro. Moreover, using the transfected miR-743b-3p mimics/inhibitors into the senescent hepatocyte AML12. We found that miR-743b-3p inhibition reversed the hepatocyte senescence, and finally decreased the expression of genes involved in lipid synthesis(Chrebp, Fabp4, Acly and Pparγ) through increasing the target gene expression of PPM1K which regulated the expression of branched-chain amino acids (BCAA) metabolism-related genes (Bckdhα, Bckdk, Bcat2, Dbt). These results identify that age-induced expression of miR-743b-3p inhibits its target PPM1K which induces BCAA metabolic disorder and regulates hepatocyte lipid accumulation during ageing. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Potential antioxidant and cytotoxic impacts of defatted extract rich in flavonoids from Styphnolobium japonicum leaves growing in Egypt.
- Author
-
El‑Feky, Amal M. and Mohammed, Nadia A.
- Subjects
TREATMENT effectiveness ,LIVER cells ,CYTOTOXINS ,FREE radicals ,OXIDANT status - Abstract
Styphnolobium japonicum leaves are considered a rich source of flavonoids, which are the prospective basis for various therapeutic effects. However, there has been a lack of comprehensive cytotoxic studies conducted on these leaves. Therefore, this ongoing investigation aimed to detect and isolate the flavonoids present in S. japonicum leaves, and assess their antioxidant and anticancer properties. The defatted extract from S. japonicum leaves was analyzed using HPLC, which resulted in the identification of seven phenolics and six flavonoids. Rutin and quercetin were found to be the most abundant. Furthermore, a comprehensive profile of flavonoids was obtained through UPLC/ESI–MS analysis in negative acquisition mode. Fragmentation pathways of the identified flavonoids were elucidated to gain relevant insights into their structural characteristics. Furthermore, genistein 7-O-glucoside, quercetin 3-O-rutinoside, and kaempferol 3-O-α-L-rhamnopyranosyl-(1 → 6)-β-D-glucopyranosyl-(1 → 2)-β-D-glucopyranoside were isolated and characterized. The defatted extract rich in flavonoids exhibited significant antioxidant, iron-reducing, free radicals scavenging impacts, and remarkable cytotoxicity against the liver cell line (IC
50 337.9μg/ mL) and lung cell line (IC50 55.0 μg/mL). Furthermore, the antioxidant and anticancer capacities of the three isolated flavonoids have been evaluated, and it has been observed that their effects are concentration-dependent. The findings of this research highlight the promising impact of flavonoids in cancer therapy. It is recommended that future scientific investigations prioritize the exploration of the distinct protective and therapeutic characteristics of S. japonicum leaves, which hold significant potential as a valuable natural resource. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
32. Rumen Microbiota Transplantation Alleviates Gossypol Diet-Induced Reproductive, Liver, and Intestinal Damage in Male Mice.
- Author
-
Zhang, Chen, Lu, Wenguang, Liu, Huiru, Shen, Lingwei, Zhu, Mengfan, Zhou, Tangtang, Zhang, Ling, Xiao, Dingfu, and Chen, Lijuan
- Subjects
LIVER cells ,GOSSYPOL ,BLOOD lactate ,PATHOLOGICAL physiology ,ALANINE aminotransferase ,ASPARTATE aminotransferase - Abstract
Simple Summary: The rumen microbiota exerts multiple physiological effects. We attempted to assess whether rumen microbiota transplantation improved the symptoms of gossypol poisoning. Male mice transplanted with the ruminant rumen microbiota of Hu sheep showed relief from reproductive and liver damage induced by a gossypol diet. Supplementing the rumen microbiota increased animal feed intake and enhanced intestinal structural integrity. Ruminants exhibit stronger tolerance to gossypol, an anti-nutritional factor, compared to monogastric animals. We transplanted Hu sheep rumen microbiota into male mice to investigate the role of rumen microbiota in animal gossypol tolerance. Thirty specific-pathogen-free (SPF) male C57BL/6 mice were randomly divided into three groups: normal diet (CK group), gossypol diet (FG group), and rumen microbiota transplantation (FMT group, gossypol diet). The pathological changes in the liver and small intestine of the mice, the organ coefficient, and sperm parameters were analyzed. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in the blood and lactate dihydrogen-X (LDH-X) levels in the testicular tissue were also measured. The results showed that body weight, feed intake, sperm concentration, sperm motility, and LDH-X levels in the FMT group increased (p < 0.05) compared with the FG group, while the enzyme activities of ALT, AST, and AST/ALT decreased (p < 0.05). In the FMT group, the injury to liver cells was alleviated, the structure of the small intestine was intact, and the villus height and the ratio of villus height to crypt depth (V/C) were higher than those in the FG group (p < 0.05). And there were no differences in various organ coefficients and sperm deformity rates among the three groups (p > 0.05), but compared with the FG group, mice in the FMT group showed tendencies closer to those in the CK group. Rumen microbiota transplantation relieved the reproductive toxicity and liver damage induced by gossypol in male mice and improved the tolerance of recipient animals to gossypol. Additionally, rumen microbes improved the intestinal structural integrity of recipients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Ameliorating effects of Lactobacillus probiotics on cadmium-induced hepatotoxicity, inflammation, and oxidative stress in Wistar rats.
- Author
-
Kohan, Arezu and Keshtmand, Zahra
- Subjects
HEMATOXYLIN & eosin staining ,LIVER cells ,LABORATORY rats ,HEPATOTOXICOLOGY ,CADMIUM chloride - Abstract
Cadmium (Cd) causes significant oxidative stress, which can lead to major clinical complications and tissue destruction. In this study, the antioxidant and anti-inflammatory effects of a mixture of Iranian probiotic strains were evaluated in Cd-exposed rats. Twenty-one adult male Wistar rats were randomized into three groups of seven rats: the control group, Cd-treated (3 mg/kg, a single dose) animals, and the rats treated with Cd + probiotic (Cd + Pro) for 30 days. Histological changes were assessed using hematoxylin and eosin staining, as well as Masson's trachoma staining. The qRT-PCR method was used for evaluating pro-inflammatory genes' expression. Liver biomarkers (ALT, ALP, and AST), biochemical enzymes, and blood parameters were measured using commercial kits, and hematological parameters were determined in both Cd- and the Cd + Pro–treated groups. Histopathologically, results revealed that the native probiotic mixture improved the function of Cd-treated liver cells, compared with Cd-treated rats. Also, positive changes of blood parameters and liver biomarker were observed in the treated group compared with the Cd-treated group. There was a down-regulation of TNF-α and IL-6 genes' expression in Cd + Pro–treated compared with the Cd-treated group. In addition, Cd + Pro–treated rats displayed lower production of lipid peroxides, lower levels of hepatic toxicity biomarkers, and increased levels of CAT and SOD antioxidant biomarkers compared to Cd-treated animals. Iranian native probiotics showed antioxidant and anti-inflammatory properties, and it is suggested to investigate their health benefits in animal studies in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. A rule-based multiscale model of hepatic stellate cell plasticity: Critical role of the inactivation loop in fibrosis progression.
- Author
-
Bouguéon, Matthieu, Legagneux, Vincent, Hazard, Octave, Bomo, Jérémy, Siegel, Anne, Feret, Jérôme, and Théret, Nathalie
- Subjects
LIVER cells ,MULTISCALE modeling ,HEPATIC fibrosis ,RNA sequencing ,FIBROSIS - Abstract
Hepatic stellate cells (HSC) are the source of extracellular matrix (ECM) whose overproduction leads to fibrosis, a condition that impairs liver functions in chronic liver diseases. Understanding the dynamics of HSCs will provide insights needed to develop new therapeutic approaches. Few models of hepatic fibrosis have been proposed, and none of them include the heterogeneity of HSC phenotypes recently highlighted by single-cell RNA sequencing analyses. Here, we developed rule-based models to study HSC dynamics during fibrosis progression and reversion. We used the Kappa graph rewriting language, for which we used tokens and counters to overcome temporal explosion. HSCs are modeled as agents that present seven physiological cellular states and that interact with (TGFβ1) molecules which regulate HSC activation and the secretion of type I collagen, the main component of the ECM. Simulation studies revealed the critical role of the HSC inactivation process during fibrosis progression and reversion. While inactivation allows elimination of activated HSCs during reversion steps, reactivation loops of inactivated HSCs (iHSCs) are required to sustain fibrosis. Furthermore, we demonstrated the model's sensitivity to (TGFβ1) parameters, suggesting its adaptability to a variety of pathophysiological conditions for which levels of (TGFβ1) production associated with the inflammatory response differ. Using new experimental data from a mouse model of CCl4-induced liver fibrosis, we validated the predicted ECM dynamics. Our model also predicts the accumulation of iHSCs during chronic liver disease. By analyzing RNA sequencing data from patients with non-alcoholic steatohepatitis (NASH) associated with liver fibrosis, we confirmed this accumulation, identifying iHSCs as novel markers of fibrosis progression. Overall, our study provides the first model of HSC dynamics in chronic liver disease that can be used to explore the regulatory role of iHSCs in liver homeostasis. Moreover, our model can also be generalized to fibroblasts during repair and fibrosis in other tissues. Author summary: Chronic liver diseases (CLDs) are associated with the development of fibrosis which is characterized by an abnormal deposition of extracellular matrix (ECM) leading to severe liver dysfunction. Hepatic stellate cells (HSCs) are key players in liver fibrosis driving ECM remodeling. However numerous biological processes are involved including HSC activation, proliferation, differentiation and inactivation and novel computational modeling is necessary to integrate such complex dynamics. Here, we used the Kappa graph rewriting language to develop the first rule-based model describing the HSCs dynamics during liver fibrosis and its reversion. Simulation analyses enabled us to demonstrate the critical role of the HSC inactivation loop in the development of liver fibrosis, and to identify inactivated HSCs as potential new markers of fibrosis progression. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Donor and recipient hematopoietic stem and progenitor cells mobilization in liver transplantation patients.
- Author
-
Zhi, Yao, Qiu, Wei, Tian, Guangyao, Song, Shifei, Zhao, Wenchao, Du, Xiaodong, Sun, Xiaodong, Chen, Yuguo, Huang, Heyu, Li, Jing, Yu, Ying, Li, Mingqian, and Lv, Guoyue
- Subjects
MONONUCLEAR leukocytes ,HEMATOPOIETIC stem cells ,MAJOR histocompatibility complex ,LIVER cells ,LIVER transplantation - Abstract
Background: Hematopoietic stem and progenitor cells (HSPCs) mobilize from bone marrow to peripheral blood in response to stress. The impact of alloresponse-induced stress on HSPCs mobilization in human liver transplantation (LTx) recipients remains under-investigated. Methods: Peripheral blood mononuclear cell (PBMC) samples were longitudinally collected from pre- to post-LTx for one year from 36 recipients with acute rejection (AR), 74 recipients without rejection (NR), and 5 recipients with graft-versus-host disease (GVHD). 28 PBMC samples from age-matched healthy donors were collected as healthy control (HC). Multi-color flow cytometry (MCFC) was used to immunophenotype HSPCs and their subpopulations. Donor recipient-distinguishable major histocompatibility complex (MHC) antibodies determined cell origin. Results: Before LTx, patients who developed AR after transplant contained more HSPCs in PBMC samples than HC, while the NR group patients contained fewer HSPCs than HC. After LTx, the HSPC ratio in the AR group sharply decreased and became less than HC within six months, and dropped to a comparable NR level afterward. During the one-year follow-up period, myeloid progenitors (MPs) biased differentiation was observed in all LTx recipients who were under tacrolimus-based immunosuppressive treatment. During both AR and GVHD episodes, the recipient-derived and donor-derived HSPCs mobilized into the recipient's blood-circulation and migrated to the target tissue, respectively. The HSPCs percentage in blood reduced after the disease was cured. Conclusions: A preoperative high HSPC ratio in blood characterizes recipients who developed AR after LTx. Recipients exhibited a decline in blood-circulating HSPCs after transplant, the cells mobilized into the blood and migrated to target tissue during alloresponse. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin.
- Author
-
Jiang, Kuan, Tian, Kaisong, Yu, Yifei, Wu, Ercan, Yang, Min, Pan, Feng, Qian, Jun, and Zhan, Changyou
- Subjects
KUPFFER cells ,DOXORUBICIN ,INTRAHEPATIC bile ducts ,LIVER cells ,INFORMATION design ,CLINICAL medicine - Abstract
Intrahepatic accumulation dominates organ distribution for most nanomedicines. However, obscure intrahepatic fate largely hampers regulation on their in vivo performance. Herein, PEGylated liposomal doxorubicin is exploited to clarify the intrahepatic fate of both liposomes and the payload in male mice. Kupffer cells initiate and dominate intrahepatic capture of liposomal doxorubicin, following to deliver released doxorubicin to hepatocytes with zonated distribution along the lobule porto-central axis. Increasing Kupffer cells capture promotes doxorubicin accumulation in hepatocytes, revealing the Kupffer cells capture-payload release-hepatocytes accumulation scheme. In contrast, free doxorubicin is overlooked by Kupffer cells, instead quickly distributing into hepatocytes by directly crossing fenestrated liver sinusoid endothelium. Compared to free doxorubicin, liposomal doxorubicin exhibits sustained metabolism/excretion due to the extra capture-release process. This work unveils the pivotal role of Kupffer cells in intrahepatic traffic of PEGylated liposomal therapeutics, and quantitively describes the intrahepatic transport/distribution/elimination process, providing crucial information for guiding further development of nanomedicines. Here, authors looked at the roles of Kupffer cells in determining intrahepatic traffic of PEGylated liposomal doxorubicin, providing information for design and clinical applications of liposomal therapeutics. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. Synergistic Effect of Doxorubicin and Blue Light Irradiation on the Antitumor Treatment of HepG2 Cells in Liver Cancer.
- Author
-
Teng, Yun, Li, Zhige, Liu, Junsong, Teng, Lesheng, and Li, Hongdong
- Subjects
CELL migration inhibition ,LIVER cells ,BLUE light ,LIVER cancer ,REACTIVE oxygen species - Abstract
Doxorubicin (DOX) has been an effective antitumor agent for human liver cancer cells; however, an overdose might lead to major side effects appearing in clinical applications. In this work, we present a strategy of combining DOX and blue light (BL) irradiation for the antitumor treatment of HepG2 cells (one typical human liver cancer cell line). It is demonstrated that synergetic DOX and BL can significantly reduce cell proliferation and increase the apoptotic rate of HepG2 cells in comparison to individual DOX treatment. The additional BL irradiation is further helpful for enhancing the inhibition of cell migration and invasion. Analyses of reactive oxygen species (ROS) level and Western blotting reveal that the strategy results in more ROS accumulation, mitochondrial damage, and the upregulation of proapoptotic protein (Bcl-2) and downregulation of antiapoptotic protein (Bax). In addition to the improved therapeutic effect, the non-contact BL irradiation is greatly helpful for reducing the dosage of DOX, and subsequently reduces the side effects caused by the DOX drug. These findings offer a novel perspective for the therapeutic approach toward liver cancer with high efficiency and reduced side effects. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Sub-Chronic Methomyl Exposure Induces Oxidative Stress and Inflammatory Responses in Zebrafish with Higher Female Susceptibility.
- Author
-
Li, Mingxiao, Chen, Xi, Song, Chao, Xu, Jing, Fan, Limin, Qiu, Liping, Li, Dandan, Xu, Huimin, Meng, Shunlong, Mu, Xiyan, Xia, Bin, and Ling, Jun
- Subjects
LIVER cells ,GENETIC regulation ,WATER pollution ,ENDOCRINE disruptors ,GENETIC transcription - Abstract
The widespread use of carbamate pesticides has raised significant environmental and health concerns, particularly regarding water contamination and the disruption of defense systems in organisms. Despite these concerns, research on the differential impacts of pesticides on male and female organisms remains limited. This study focused on methomyl, investigating sex-specific differences in liver antioxidant defenses and inflammatory response indices in male and female zebrafish after 56 days of exposure to environmentally relevant concentrations (0, 0.05, 0.10, and 0.20 mg/L). Our findings indicate that methomyl exposure significantly increased ROS content in zebrafish livers, inducing oxidative stress and activating enzymatic antioxidant defenses such as SOD, CAT, and GSH-Px activities. Sub-chronic exposure altered the expression of apoptosis-related genes (Bax/Bcl2a and Caspases3a), resulting in liver cell apoptosis in a concentration-dependent manner, with the 0.20 mg/L concentration causing the most severe damage. Additionally, methomyl exposure at environmentally relevant concentrations triggered persistent inflammatory responses in liver tissues, evidenced by increased transcription levels of inflammatory factor genes and the activation of toll-like receptors, heightening susceptibility to exogenous allergens. It is noteworthy that oxidative damage indicators (AST, ROS, MDA) and inflammatory gene expressions (IL-1β, TNF-α) were significantly higher in female livers compared to male livers at 0.10–0.20 mg/L methomyl exposure. Consequently, our study underscores the potential adverse effects of environmental methomyl exposure on aquatic organisms and highlights the need for heightened consideration of the risks posed by environmental endocrine disruptors to female health and safety. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Apomorphine Suppresses the Progression of Steatohepatitis by Inhibiting Ferroptosis.
- Author
-
Maeda, Hiroshi, Miura, Kouichi, Aizawa, Kenichi, Bat-Erdene, Oyunjargal, Sashikawa-Kimura, Miho, Noguchi, Eri, Watanabe, Masako, Yamada, Naoya, Osaka, Hitoshi, Morimoto, Naoki, and Yamamoto, Hironori
- Subjects
APOMORPHINE ,FATTY liver ,CELL death ,NUCLEAR factor E2 related factor ,LIVER cells - Abstract
The role of ferroptosis in steatohepatitis development is largely unknown. We investigated (1) whether hepatocyte ferroptosis occurs in a gene-modified steatohepatitis model without modifying dietary components, (2) whether ferroptosis occurs at an early stage of steatohepatitis, and (3) whether apomorphine, recently reported as a ferroptosis inhibitor, can ameliorate steatohepatitis. Hepatocyte-specific PTEN KO mice were used. Huh 7 and primary cultured hepatocytes isolated from the mice were used in this study. The number of dead cells increased in 10-week-old PTEN KO mice. This cell death was suppressed by the administration of ferroptosis inhibitor ferrostatin-1 for 2 weeks. Apomorphine also ameliorated the severity of steatohepatitis. Treatment with ferroptosis inhibitors, including apomorphine, decreases the level of lipid peroxidase. Apomorphine suppressed cell death induced by RSL-3 (a ferroptosis inducer), which was not suppressed by apoptosis or necroptosis inhibitors. Apomorphine showed a radical trapping capacity with much more potent activity than ferrostatin-1 and Trolox, a soluble form of vitamin E. In addition, apomorphine activated nrf2 and its downstream genes, including HO-1 and xCT. In conclusion, ferroptosis occurs in steatohepatitis from an early stage in PTEN KO mice. In addition, apomorphine ameliorates the severity of steatohepatitis by inhibiting ferroptosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. Investigation of Degradation and Biocompatibility of Indirect 3D-Printed Bile Duct Stents.
- Author
-
Lee, Ming-Chan, Pan, Cheng-Tang, Huang, Ruo-Jiun, Ou, Hsin-You, Yu, Chun-Yen, and Shiue, Yow-Ling
- Subjects
BILE ducts ,MECHANICAL behavior of materials ,THREE-dimensional printing ,LIVER cells ,LACTIC acid - Abstract
This study proposes a bile duct stent based on indirect 3D printing technology. Four ratio materials were synthesized from lactic acid (LA) and glycolide (GA) monomers by melt polymerization: PLA, PLGA (70:30), PLGA (50:50), and PLGA (30:70). The four kinds of material powders were preliminarily degraded, and the appearance was observed with an optical microscope (OM) and a camera. The weight and appearance of the four materials changed significantly after four weeks of degradation, which met the conditions for materials to be degraded within 4–6 weeks. Among them, PLGA (50:50) lost the most—the weight dropped to 13.4%. A stent with an outer diameter of 10 mm and an inner diameter of 8 mm was successfully manufactured by indirect 3D printing technology, demonstrating the potential of our research. Then, the degradation experiment was carried out on a cylindrical stent with a diameter of 6 mm and a height of 3 mm. The weight loss of the sample was less than that of the powder degradation, and the weight loss of PLGA (50:50) was the largest—the weight dropped to 79.6%. The nano-indenter system measured the mechanical properties of materials. Finally, human liver cancer cells Hep-3B were used to conduct in vitro cytotoxicity tests on the scaffolds to test the biocompatibility of the materials. A bile duct stent meeting commercial size requirements has been developed, instilling confidence in the potential of our research for future medical applications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. A Comparison of Common Quantum Dot Alternatives to Cadmium-Based Quantum Dots on the Basis of Liver Cytotoxicity.
- Author
-
Harris, Seth and Kim, Kyoungtae
- Subjects
QUANTUM dots ,LIVER cells ,CYTOTOXINS ,CELL adhesion ,LIVER ,REACTIVE oxygen species ,TRANSCRIPTOMES - Abstract
Fluorescent nanoparticles known as quantum dots (QDs) have unique properties that make them useful in biomedicine. Specifically, CdSe/ZnS QDs, while good at fluorescing, show toxicity. Due to this, safer alternatives have been developed. This study uses a tetrazolium dye (XTT) viability assay, reactive oxygen species (ROS) fluorescent imaging, and apoptosis to investigate the effect of QD alternatives InP/ZnS, CuInS
2 /ZnS, and nitrogen-doped carbon dots (NCDs) in liver cells. The liver is a possible destination for the accumulation of QDs, making it an appropriate model for testing. A cancerous liver cell line known as HepG2 and an immortalized liver cell line known as THLE-2 were used. At a nanomolar range of 10–150, HepG2 cells demonstrated no reduced cell viability after 24 h. The XTT viability assay demonstrated that CdSe/ZnS and CuInS2 /ZnS show reduced cell viability in THLE-2 cells with concentrations between 50 and 150 nM. Furthermore, CdSe/ZnS- and CuInS2 /ZnS-treated THLE-2 cells generated ROS as early as 6 h after treatment and elevated apoptosis after 24 h. To further corroborate our results, apoptosis assays revealed an increased percentage of cells in the early stages of apoptosis for CdSe/ZnS-treated (52%) and CuInS2 /ZnS-treated (38%) THLE-2. RNA transcriptomics revealed heavy downregulation of cell adhesion pathways such as wnt, cadherin, and integrin in all QDs except NCDs. In conclusion, NCDs show the least toxicity toward these two liver cell lines. While demonstrating less toxicity than CdSe/ZnS, the metallic QDs (InP/ZnS and CuInS2 /ZnS) still demonstrate potential concerns in liver cells. This study serves to explore the toxicity of QD alternatives and better understand their cellular interactions. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
42. Depletion of Activated Hepatic Stellate Cells and Capillarized Liver Sinusoidal Endothelial Cells Using a Rationally Designed Protein for Nonalcoholic Steatohepatitis and Alcoholic Hepatitis Treatment.
- Author
-
Mishra, Falguni, Yuan, Yi, Yang, Jenny J., Li, Bin, Chan, Payton, and Liu, Zhiren
- Subjects
KUPFFER cells ,LIVER cells ,NON-alcoholic fatty liver disease ,ENDOTHELIAL cells ,HEPATITIS ,INTEGRINS ,CELL adhesion molecules - Abstract
Nonalcoholic steatohepatitis (NASH) and alcoholic hepatitis (AH) affect a large part of the general population worldwide. Dysregulation of lipid metabolism and alcohol toxicity drive disease progression by the activation of hepatic stellate cells and the capillarization of liver sinusoidal endothelial cells. Collagen deposition, along with sinusoidal remodeling, alters sinusoid structure, resulting in hepatic inflammation, portal hypertension, liver failure, and other complications. Efforts were made to develop treatments for NASH and AH. However, the success of such treatments is limited and unpredictable. We report a strategy for NASH and AH treatment involving the induction of integrin α
v β3 -mediated cell apoptosis using a rationally designed protein (ProAgio). Integrin αv β3 is highly expressed in activated hepatic stellate cells (αHSCs), the angiogenic endothelium, and capillarized liver sinusoidal endothelial cells (caLSECs). ProAgio induces the apoptosis of these disease-driving cells, therefore decreasing collagen fibril, reversing sinusoid remodeling, and reducing immune cell infiltration. The reversal of sinusoid remodeling reduces the expression of leukocyte adhesion molecules on LSECs, thus decreasing leukocyte infiltration/activation in the diseased liver. Our studies present a novel and effective approach for NASH and AH treatment. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
43. Disturbed intracellular folate homeostasis impairs autophagic flux and increases hepatocytic lipid accumulation.
- Author
-
Chi, Wan-Yu, Lee, Gang-Hui, Tang, Ming-Jer, Chen, Bing-Hung, Lin, Wei-Ling, and Fu, Tzu-Fun
- Subjects
FOLIC acid ,HOMEOSTASIS ,FATTY liver ,LIPID metabolism ,LIVER cells ,LIPIDS - Abstract
Background: Metabolic associated fatty liver disease (MAFLD), a prevalent liver disorder affecting one-third of the global population, encompasses a spectrum ranging from fatty liver to severe hepatic steatosis. Both genetic and lifestyle factors, particularly diet and nutrition, contribute to its etiology. Folate deficiency, a frequently encountered type of malnutrition, has been associated with the pathogenesis of MAFLD and shown to impact lipid deposition. However, the underlying mechanisms of this relationship remain incompletely understood. We investigated the impact of disturbed folate-mediated one-carbon metabolism (OCM) on hepatic lipid metabolism both in vitro using human hepatoma cells and in vivo using transgenic fluorescent zebrafish displaying extent-, stage-, and duration-controllable folate deficiency upon induction. Results: Disturbed folate-mediated one-carbon metabolism, either by inducing folate deficiency or adding anti-folate drug, compromises autophagy and causes lipid accumulation in liver cells. Disturbed folate status down-regulates cathepsin L, a key enzyme involved in autophagy, through inhibiting mTOR signaling. Interfered mitochondrial biology, including mitochondria relocation and increased fusion-fission dynamics, also occurs in folate-deficient hepatocytes. Folate supplementation effectively mitigated the impaired autophagy and lipid accumulation caused by the inhibition of cathepsin L activity, even when the inhibition was not directly related to folate deficiency. Conclusions: Disruption of folate-mediated OCM diminishes cathepsin L expression and impedes autophagy via mTOR signaling, leading to lipid accumulation within hepatocytes. These findings underscore the crucial role of folate in modulating autophagic processes and regulating lipid metabolism in the liver. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Plant-mediated synthesis of selenium nanoparticles using Caccinia macranthera extract and assessment of their antioxidant and cytotoxic properties.
- Author
-
Hosseinpour, Leili, Baharara, Javad, Bostanabad, Saeed Zaker, and Darroudi, Majid
- Subjects
SUSTAINABLE chemistry ,LIVER cells ,SELENIUM ,NANOPARTICLES ,CANCER cells ,P53 antioncogene ,LIVER regeneration - Abstract
Objective(s): The current study aims to achieve synthesized selenium nanoparticles (Se-NPs) through a green chemistry route using sodium selenite (Na
2 SeO3 ) and Caccinia macranthera (C. macranthera) plant extract as stabilizing and reducing agents and to investigate the anticancer effects of the synthesized NPs. Materials and Methods: The outcomes affirmed the successful production of the synthesized Se-NPs, as their spherical framework and particle size scale of 54 to 60 nm were exhibited by the images of FESEM/PSA. This spherical frame was also detected in the TEM images at a size of 11.5 nm. The inhibitory effect of Se-NPs was investigated on the proliferation of human liver cancer cells (Huh-7). Additionally, the effect of Se-NPs was studied on the expression of the implicated genes throughout the cell apoptosis using the Real- Time PCR technique. Also, the percentage of apoptotic cells was obtained using Annexin V/PI and DAPI kits. Finally, flow cytometry was exerted to determine the amount of produced ROS. Results: The results of laboratory studies showed that Se-NPs can significantly reduce the survival of Huh-7 cancer cells in dosage and time-reliant behavior, while they have very little toxicity on normal L929 cells. Also, Se-NPs were able to induce apoptosis in liver cancer cells, which was observed along with the increased expression of Bax, p53, Caspase3, and Caspase 9 genes. In addition, Se-NPs increased the production of ROS in Huh-7 cells and led to an increase in oxidative stress in these cells. Conclusion: Therefore, these NPs can be used in clinical studies of liver cancer. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
45. Research on Hepatocyte Regulation of PCSK9-LDLR and Its Related Drug Targets.
- Author
-
Liu, Su-su, Yu, Tong, Qiao, Yan-fang, Gu, Shu-xiao, and Chai, Xin-lou
- Subjects
DRUG therapy for hyperlipidemia ,THERAPEUTIC use of protease inhibitors ,ENDOCYTOSIS ,ANTILIPEMIC agents ,HYPERLIPIDEMIA ,HOMEOSTASIS ,LIVER cells ,PROTEASE inhibitors ,LOW density lipoproteins ,MEDICAL research ,PROTEOLYTIC enzymes ,DRUG development ,PHARMACODYNAMICS ,DISEASE complications - Abstract
The prevalence of hyperlipidemia has increased significantly due to genetic, dietary, nutritional and pharmacological factors, and has become one of the most common pathological conditions in humans. Hyperlipidemia can lead to a range of diseases such as atherosclerosis, stroke, coronary heart disease, myocardial infarction, diabetes, and kidney failure, etc. High circulating low-density lipoprotein cholesterol (LDL-C) is one of the causes of hyperlipidemia. LDL-C in the blood binds to LDL receptor (LDLR) and regulates cholesterol homeostasis through endocytosis. In contrast, proprotein convertase subtilisin/kexin type 9 (PCSK9) mediates LDLR degradation via the intracellular and extracellular pathways, leading to hyperlipidemia. Targeting PCSK9-synthesizing transcription factors and downstream molecules are important for development of new lipid-lowering drugs. Clinical trials regarding PCSK9 inhibitors have demonstrated a reduction in atherosclerotic cardiovascular disease events. The purpose of this review was to explore the target and mechanism of intracellular and extracellular pathways in degradation of LDLR and related drugs by PCSK9 in order to open up a new pathway for the development of new lipid-lowering drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. γ-glutamyl transpeptidase activatable NIR photosensitizer for visualization and selective killing of liver cancer cells.
- Author
-
Feng, Qincong, Li, Zhipeng, and Shen, Jianliang
- Subjects
- *
LIVER cancer , *FLUORESCENCE yield , *GAMMA-glutamyltransferase , *LIVER cells , *CANCER cells , *PHOTOSENSITIZERS - Abstract
Photodynamic therapy (PDT) is a treatment model that involves using light sources to excite photosensitizers (PSs), generating reactive oxygen species. This method is considered a potential treatment for tumors. However, the non-selective toxicity of traditional PSs to both tumors and normal tissues hinders the advancement of PDT. This lack of selectivity is a major obstacle in the development of effective PDT. The activatable PS can only function in a specific environment, which enhances the selectivity and safety of PDT. In this paper, we focus on GGT (γ-glutamyltranspeptidase) overexpressed in liver cancer as the biological target. We designed and synthesized the activatable PS BrCy-Glu by modifying the substrate of GGT (l -glutamic acid) onto the brominated hemicyanine PS (BrCy-OH). The intramolecular charge transfer (ICT) effect of BrCy-Glu is inhibited, which leads to low fluorescence quantum yield and singlet oxygen yield. However, in the presence of GGT, it can undergo selective hydrolysis and be converted into BrCy-OH through a series of elimination reactions. This process is accompanied by a significant increase in fluorescence quantum yield and singlet oxygen yield. In vitro studies demonstrate that BrCy-Glu is suitable for precise fluorescence identification of liver cancer and selective eradication of cancer cells under light conditions. [Display omitted] • A new near infrared photosensitizer was developed for imaging and treatment of cancer cells with high GGT enzyme expression. • This new activatable near infrared photosensitizer can only play a role in specific tumor microenvironment, which enhances the effectiveness and safety of PDT. • The new strategy of killing liver cancer by activating photosensitizer tracing and photodynamic therapy may be very important for cancer treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Role of liver sinusoidal endothelial cell in metabolic dysfunction-associated fatty liver disease.
- Author
-
He, Qiongyao, He, Wu, Dong, Hui, Guo, Yujin, Yuan, Gang, Shi, Xiaoli, Wang, Dingkun, and Lu, Fuer
- Subjects
FATTY liver ,HEPATIC fibrosis ,BLOOD cells ,ENDOTHELIAL cells ,LIVER cells ,LIVER - Abstract
Liver sinusoidal endothelial cells (LSECs) are highly specialized endothelial cells that represent the interface between blood cells on one side and hepatocytes on the other side. LSECs not only form a barrier within the hepatic sinus, but also play important physiological functions such as regulating hepatic vascular pressure, anti-inflammatory and anti-fibrotic. Pathologically, pathogenic factors can induce LSECs capillarization, that is, loss of fenestra and dysfunction, which are conducive to early steatosis, lay the foundation for the progression of metabolic dysfunction-associated fatty liver disease (MAFLD), and accelerate metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis. The unique localization, phenotype, and function of LSECs make them potential candidates for reducing liver injury, inflammation, and preventing or reversing fibrosis in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. PHD2 enzyme is an intracellular manganese sensor that initiates the homeostatic response against elevated manganese.
- Author
-
Gurol, Kerem C., Jursa, Thomas, Eun Jeong Cho, Fast, Walter, Dalby, Kevin N., Smith, Donald R., and Mukhopadhyay, Somshuvra
- Subjects
ENDOENZYMES ,MANGANESE ,HYPOXIA-inducible factors ,LIVER cells ,DETECTORS - Abstract
Intracellular sensors detect changes in levels of essential metals to initiate homeostatic responses. But, a mammalian manganese (Mn) sensor is unknown, representing a major gap in understanding of Mn homeostasis. Using human-relevant models, we recently reported that: 1) the primary homeostatic response to elevated Mn is upregulation of hypoxia-inducible factors (HIFs), which increases expression of the Mn efflux transporter SLC30A10; and 2) elevated Mn blocks the prolyl hydroxylation of HIFs by prolyl hydroxylase domain (PHD) enzymes, which otherwise targets HIFs for degradation. Thus, the mammalian mechanism for sensing elevated Mn likely relates to PHD inhibition. Moreover, 1) Mn substitutes for a catalytic iron (Fe) in PHD structures; and 2) exchangeable cellular levels of Fe and Mn are comparable. Therefore, we hypothesized that elevated Mn directly inhibits PHD by replacing its catalytic Fe. In vitro assays using catalytically active PHD2, the primary PHD isoform, revealed that Mn inhibited, and Fe supplementation rescued, PHD2 activity. However, a mutation in PHD2 (D315E) that selectively reduced Mn binding without substantially impacting Fe binding or enzymatic activity resulted in complete insensitivity of PHD2 to Mn in vitro. Additionally, hepatic cells expressing full-length PHD2
D315E were less sensitive to Mn-induced HIF activation and SLC30A10 upregulation than PHD2wild-type . These results: 1) define a fundamental Mn sensing mechanism for controlling Mn homeostasis--elevated Mn inhibits PHD2, which functions as a Mn sensor, by outcompeting its catalytic Fe, and PHD2 inhibition activates HIF signaling to up-regulate SLC30A10; and 2) identify a unique mode of metal sensing that may have wide applicability. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
49. Comprehensive bioinformatics analysis of integrator complex subunits: expression patterns, immune infiltration, and prognostic signature, validated through experimental approaches in hepatocellular carcinoma.
- Author
-
Xu, Yifei, Liao, Wenlian, Wang, Ting, Zhang, Liwei, and Zhang, Hui
- Subjects
GENE expression ,REVERSE transcriptase polymerase chain reaction ,RNA polymerase II ,KILLER cells ,LIVER cells ,HEPATOCELLULAR carcinoma - Abstract
Background: Hepatocellular carcinoma (HCC) is a common gastrointestinal malignancy with a high incidence and poor prognosis. The subunits of the integrator complex (INTS1-14) play a crucial role in regulating genes dependent on RNA Polymerase II, which may be associated with cancer. However, the role of INTSs in HCC remains unclear. This study aims to comprehensively analyze the clinical value and potential role of INTS family genes in HCC through systematic bioinformatics analysis. Methods: We employed various public databases, including UALCAN, HPA, Kaplan–Meier Plotter, GEPIA2, TNMplot, STRING, TIMER, and TISIDB, to investigate the expression levels, clinicopathological correlations, diagnostic and prognostic value, genetic alterations, co-expression network, molecular targets, and immune infiltration of INTSs in HCC. Additionally, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) were utilized to investigate the biological functions of genes associated with INTSs. Furthermore, Western blot, real-time fluorescence quantitative reverse transcription polymerase chain reaction (RT-qPCR), and immunohistochemistry techniques were employed to assess the expression of relevant proteins and genes. The proliferation of HCC cells was evaluated using the CCK8 assay. Results: We found that in HCC, there was a significant upregulation of INTSs at the transcriptional level, particularly INTS1, INTS4, INTS7, and INTS8. Additionally, the protein levels of INTS1 and INTS8 were notably elevated. The overexpression of these INTSs was strongly correlated with tumor stages in HCC patients. INTS1, INTS4, INTS7, and INTS8 exhibited significant diagnostic and prognostic value in HCC. Moreover, their expression was associated with immune infiltrations and activated status, including B cells, CD8 + T cells, CD4 + T cells, NK cells, macrophages, and dendritic cells. Functional predictions indicated that INTS1, INTS4, INTS7, and INTS8 were involved in various cancer-related signaling pathways, such as TRAIL, IFN-gamma, mTOR, CDC42, Apoptosis, and the p53 pathway. Furthermore, we observed a significant upregulation of INTS1, INTS4, INTS7, and INTS8 expression in HCC cell lines compared to normal liver cell lines. The level of INTS1 protein was higher in cancerous tissues compared to adjacent non-cancerous tissues (n = 16), and the suppression of INTS1 resulted in a significant decrease in the proliferation of Huh7 cells. Conclusion: These findings indicate the potential of INTS family genes as diagnostic biomarkers and therapeutic targets in HCC. Further research is needed to understand the underlying mechanisms and explore clinical applications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. HNF4A and HNF1A exhibit tissue specific target gene regulation in pancreatic beta cells and hepatocytes.
- Author
-
Ng, Natasha Hui Jin, Ghosh, Soumita, Bok, Chek Mei, Ching, Carmen, Low, Blaise Su Jun, Chen, Juin Ting, Lim, Euodia, Miserendino, María Clara, Tan, Yaw Sing, Hoon, Shawn, and Teo, Adrian Kee Keong
- Subjects
PANCREATIC beta cells ,MATURITY onset diabetes of the young ,GENETIC regulation ,LIVER cells ,TYPE 2 diabetes ,GENE expression - Abstract
HNF4A and HNF1A encode transcription factors that are important for the development and function of the pancreas and liver. Mutations in both genes have been directly linked to Maturity Onset Diabetes of the Young (MODY) and type 2 diabetes (T2D) risk. To better define the pleiotropic gene regulatory roles of HNF4A and HNF1A, we generated a comprehensive genome-wide map of their binding targets in pancreatic and hepatic cells using ChIP-Seq. HNF4A was found to bind and regulate known (ACY3, HAAO, HNF1A, MAP3K11) and previously unidentified (ABCD3, CDKN2AIP, USH1C, VIL1) loci in a tissue-dependent manner. Functional follow-up highlighted a potential role for HAAO and USH1C as regulators of beta cell function. Unlike the loss-of-function HNF4A/MODY1 variant I271fs, the T2D-associated HNF4A variant (rs1800961) was found to activate AKAP1, GAD2 and HOPX gene expression, potentially due to changes in DNA-binding affinity. We also found HNF1A to bind to and regulate GPR39 expression in beta cells. Overall, our studies provide a rich resource for uncovering downstream molecular targets of HNF4A and HNF1A that may contribute to beta cell or hepatic cell (dys)function, and set up a framework for gene discovery and functional validation. Here, the authors generated a genome-wide map of the global targets bound by HNF4A and HNF1A in beta cells and hepatic cells, and highlighted notable downstream pathways and target genes that may influence beta cell function. This approach also shed light on a potentially activating effect of a HNF4A type 2 diabetes risk variant. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.